期刊文献+

Sysmex-CA 7000全自动凝血仪性能评价 被引量:5

Performance Evaluation of CA-7000 Automatic Coagulometer System
原文传递
导出
摘要 目的:评价Sysmex-CA7000全自动凝血仪的性能。方法:选择活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、凝血酶原时间(PT)四个常用凝血检测项目分别从仪器检测准确性、精密度,抗干扰性及参考范围几方面对SysmexCA7000凝血仪进行性能验证。结果:四个项目准确性验证结果均符合厂家要求(CV%<5%),但低值样本PT(CV3.13%)和TT(CV3.36%)准确性不及其他几个项目;批内和批间精密度检测均满足厂家要求,且除PT外其余三个项目远低于厂家要求CV%;参考范围验证和抗干扰能力结果显示四个检测项目均较理想。结论:Sysmex CA7000凝血仪具有检测准确性好、精密度高、检测范围宽、抗干扰能力强等特点,值得临床推广应用。 Objective: To evaluate the performance of CA-7000 automatic coagulometer system. Methods: Items of prothrombin time (PT), activatedpartial thromboplastintime (APTT), thrombin time (TT) Fibrinogen (Fg), were included to evaluate the CA-7000 automatic coagulometer system of accuracy, precision, interference and reference range. Results: The validate result of accuracy of the four indexes were in line with the requirements of manufacturers (CV%〈5%), but accuracy of low value samples PT (CV3.13%) and TT (CV3.36%) were lower than other indexes; Detection of precision between within batch and inter batch both met the requirements of manufacturers, and the three indexes, except PT, were far below the requirements of manufacturers CV%; Reference range and ability of anti disturbance were ideal according to the four indexes. Conelusion: CA-1700 Coagulation analyzer has good characteristics of detection accuracy, high precision, wide detection range, strong anti-interference ability, it's worthy of clinical application.
出处 《现代生物医学进展》 CAS 2015年第16期3136-3138,3188,共4页 Progress in Modern Biomedicine
关键词 凝血仪 性能评价 Sysmex-CA7000 Coagulometer Performance Evaluation Sysmex-CA7000
  • 相关文献

参考文献5

二级参考文献35

  • 1李冰,朱志宏,田万管,班雨,王永伟,沈洪.血必净注射液对脓毒症大鼠肠系膜微循环动态变化的影响[J].中国全科医学,2009,12(10):857-859. 被引量:17
  • 2杨果杰,陈秀莲,邵萍,田枫,康爱君,于芳.内毒素法兔发热动物模型及其标准化的研究[J].中国实验动物学报,2001,9(4):247-250. 被引量:18
  • 3毕玫荣,张岩.新生儿凝血特点及其影响因素[J].国外医学(妇幼保健分册),2005,16(1):15-17. 被引量:48
  • 4王蔼卿,曹书华,常文秀.血必净对多器官功能障碍综合征患者血浆蛋白C活性的影响[J].天津医科大学学报,2007,13(2):235-237. 被引量:18
  • 5冯仁丰.临床检验质量管理基础[M].第2版.上海:上海科学技术文献出版社,2007:413.
  • 6Perry DJ, Fitzmaurice DA, Kitchen S, et al. Point - of - care testing inhaemostasis[ J]. Br J Haematol. 2010,150(5) :501 -514.
  • 7Plesch W, Van den Besselaar AM. Validation of the international nor-malized ratio (INR) in a new point - of - care system designed for homemonitoring of oral anticoagulation therapy [ J]. Int J Lab Hematol,2009,31(1) :20-25.
  • 8Meurin P, Tabet JY, Monchi M, et al. Accuracy of a portable interna-tional normalized ratio monitor for patients receiving a low molecularweight heparin as a bridge pending full oral anticoagulant efficacy [J].Thromb Res, 2010,125(2) : 192 -195.
  • 9Hoel RW, Albright RC,Beyer LK, et al. Correlation of point - of -care international normalized ratio to laboratory international normalizedratio in hemodialysis patients taking warfarin[ J]. Clin J Am Soc Neph-rol, 2009,4(1):99-104.
  • 10Kong MC,Lim TG, Ng HJ, et al. Feasibility,cost - effectiveness andpatientsy acceptance of point - of - care inr testing in a hospital - basedanticoagulation clinic[ J] . Ann Hematol, 2008,87(11) :905 -910.

共引文献30

同被引文献34

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部